Potential of neutrophil-to-eosinophil ratio as a new prognostic tool for patients with advanced renal cell carcinoma receiving first-line immuno-oncology combinations by Daniel Y C Heng, Kosuke Takemura

Get full text

High-risk bladder cancer: improving outcomes with perioperative chemotherapy by Daniel Y.C. Heng, Jorge A. Garcia

Get full text

Renal cell carcinoma: evolving approaches to advanced non-clear cell carcinoma by Daniel Y.C. Heng, Ronald M. Bukowski

Get full text

Renal cell carcinoma: evolving approaches to advanced non-clear cell carcinoma by Daniel Y.C. Heng, Ronald M. Bukowski

Get full text

High-risk bladder cancer: improving outcomes with perioperative chemotherapy by Daniel Y.C. Heng, Jorge A. Garcia

Get full text

Cabozantinib in the treatment of advanced renal cell carcinoma: clinical trial evidence and experience by Jose Manuel Ruiz-Morales, Daniel Y.C. Heng

Get full text

Contemporary treatment of metastatic renal cell carcinoma by Igor Stukalin, Nimira Alimohamed, Daniel Y.C. Heng

Get full text

Review: Targeted therapy for metastatic renal cell carcinoma: current treatment and future directions by Daniel Y.C. Heng, Christian Kollmannsberger, Kim N. Chi

Get full text

Corrigendum re “Impact of Body Mass Index on Survival Outcomes for Patients with Metastatic Renal Cell Carcinoma in the Immuno-oncology Era: A Systematic Review and Meta-analysis”... by Kosuke Takemura, Satoru Yonekura, Laura E. Downey, Dimitris Evangelopoulos, Daniel Y.C. Heng

Get full text

Impact of Body Mass Index on Survival Outcomes of Patients with Metastatic Renal Cell Carcinoma in the Immuno-oncology Era: A Systematic Review and Meta-analysis by Kosuke Takemura, Satoru Yonekura, Laura E. Downey, Dimitris Evangelopoulos, Daniel Y.C. Heng

Get full text

Imaging response to immune checkpoint inhibitors in patients with advanced melanoma: a retrospective observational cohort study by Mehul Gupta, Mehul Gupta, Igor Stukalin, Igor Stukalin, Daniel E. Meyers, Daniel E. Meyers, Daniel Y. C. Heng, Daniel Y. C. Heng, Jose Monzon, Jose Monzon, Tina Cheng, Tina Cheng, Vishal Navani, Vishal Navani

Get full text

Mutational signatures among young-onset testicular cancers by Nicole E. Mealey, Dylan E. O’Sullivan, Cheryl E. Peters, Daniel Y. C. Heng, Darren R. Brenner

Get full text

Evolving landscape of first-line combination therapy in advanced renal cancer: a systematic review by Aly-Khan A. Lalani, Daniel Y. C. Heng, Naveen S. Basappa, Lori Wood, Nayyer Iqbal, Deanna McLeod, Denis Soulières, Christian Kollmannsberger

Get full text

Efficacy and Safety of First-line Systemic Therapy for Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis by Nicholas A. Bosma, Matthew T. Warkentin, Chun Loo Gan, Safiya Karim, Daniel Y.C. Heng, Darren R. Brenner, Richard M. Lee-Ying

Get full text

Impact of Value Frameworks on the Magnitude of Clinical Benefit: Evaluating a Decade of Randomized Trials for Systemic Therapy in Solid Malignancies by Ellen Cusano, Chelsea Wong, Eddy Taguedong, Marcus Vaska, Tasnima Abedin, Nancy Nixon, Safiya Karim, Patricia Tang, Daniel Y. C. Heng, Doreen Ezeife

Get full text

Effectiveness of Immune Checkpoint Inhibitor with Anti-PD-1 Monotherapy or in Combination with Ipilimumab in Younger versus Older Adults with Advanced Melanoma by Taylor E. Woo, Igor Stukalin, Philip Q. Ding, Siddhartha Goutam, Michael Sander, Benjamin Ewanchuk, Winson Y. Cheung, Daniel Y. C. Heng, Tina Cheng

Get full text

Evaluation of the modified immune prognostic index to prognosticate outcomes in metastatic uveal melanoma patients treated with immune checkpoint inhibitors by Michael S. Sander, Igor Stukalin, Isabelle A. Vallerand, Siddhartha Goutam, Benjamin W. Ewanchuk, Daniel E. Meyers, Aliyah Pabani, Don G. Morris, Daniel Y. C. Heng, Tina Cheng

Get full text

The Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Metastatic Testicular Cancer by Domen Ribnikar, Igor Stukalin, Philippe L. Bedard, Robert J. Hamilton, Michael Jewett, Padraig Warde, Peter Chung, Lynn Anson-Cartwright, Arnoud J. Templeton, Eitan Amir, Aaron R. Hansen, Daniel Y. C. Heng, Jeremy Lewin

Get full text

Effectiveness and Safety of First-Line Pembrolizumab in Older Adults with PD-L1 Positive Non-Small Cell Lung Cancer: A Retrospective Cohort Study of the Alberta Immunotherapy Datab... by Heidi A. I. Grosjean, Samantha Dolter, Daniel E. Meyers, Philip Q. Ding, Igor Stukalin, Siddhartha Goutam, Shiying Kong, Quincy Chu, Daniel Y. C. Heng, D. Gwyn Bebb, Don G. Morris, Winson Y. Cheung, Aliyah Pabani

Get full text

Evaluating the impact of early identification of asymptomatic brain metastases in metastatic renal cell carcinoma by Ambica Parmar, Sunita Ghosh, Arjun Sahgal, Aly‐Khan A. Lalani, Aaron R. Hansen, M. Neil Reaume, Lori Wood, Naveen S. Basappa, Daniel Y. C. Heng, Jeffrey Graham, Christian Kollmannsberger, Denis Soulières, Rodney H. Breau, Simon Tanguay, Anil Kapoor, Frédéric Pouliot, Georg A. Bjarnason

Get full text